Write in a clean editor, then format for Diabetes Epidemiology and Management in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Diabetes Epidemiology and Management is a peer-reviewed journal published by Elsevier, covering Diabetes Management and Research, Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Diabetes Epidemiology and Management 12 (2023) 45–58.
Formats any DOI in Diabetes Epidemiology and Management style. No sign-up. |
| Publishes research in | Diabetes Management and Research Diabetes Treatment and Management Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes Management and Education Diabetes and associated disorders |
| ISSN | 2666-9706 |
| Citation impact (2-yr) | 1.23 |
| h-index | 17 |
| i10-index | 41 |
| Total citations | 1,020 |
| Article processing charge | $2,157 |
| Open access | Yes |
| Top institutions publishing here | University of Liège |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Sulphonylureas (SUs) for a long time occupied an essential role in the management of type 2 diabetes (T2D) as an alternative or a complement to metformin. However, the launch of new oral antidiabetic drugs (OADs), firstly DPP-4 inhibitors (gliptins) and more recently SGLT2 inhibitors (gliflozins), has markedly changed the scene. Indeed, in contrast to SUs,…
Evidence for clinical and quality of life benefits of Continuous Glucose Monitor (CGM) use in patients with type 1 diabetes (T1DM) is well established, but evidence in patients with type 2 diabetes (T2DM) is less robust or clear. This study aimed to help clarify the impact of CGMs for patients with T2DM and possible factors…
Objective: To estimate rates of severe hypoglycemia and falls among older adults with diabetes and evaluate their association. Research Design and Methods: Survey in an age-stratified, random sample adults with diabetes age 65-100 years; respondents were asked about severe hypoglycemia (requiring assistance) and falls in the past 12 months. Prevalence ratios (adjusted for age, sex,…
Patients’ acceptance of artificial intelligence (AI) based health-related technologies depend strongly on their perception and trust of AI. This research field has not been studied extensively, especially among people living with diabetes. A large proportion of them frequently use health technologies in their everyday lives to manage their condition, which may make them more prepared…
Atherosclerotic cardiovascular disease (ASCVD), heart failure (HF) and chronic kidney disease (CKD) are major complications of type 2 diabetes (T2DM). The objectives of preventing these complications are not fully reached in clinical practice. Sodium-glucose cotransporter 2 inhibitors (SGLT2is) have proven their efficacy in reducing major cardiovascular events, diminishing hospitalisation for HF and limiting the progression…
